c-peptide-normal-range-for-type-2-diabetes Anticancer peptides (ACPs) represent a rapidly evolving class of therapeutic agents, characterized by their ability to inhibit tumor cell proliferation and migration. These short bioactive peptides, typically composed of 10 to 60 amino acids, are being explored for their unique mechanisms of action and potential advantages over traditional cancer treatments. Their capacity to target tumor cells directly, often with fewer side effects, positions them as a significant area of research in the ongoing fight against cancer.
ACPs are short chains of amino acids that exhibit antitumor activity. They can be derived from various sources, including natural antimicrobial peptides, synthetic designs, or even through the hydrolysis of proteins found in everyday foods like rice and soyREVIEW ARTICLE Open AccessArtificial intelligence-driven anticancer peptide discoveryJunrui Wu, Shuaiqi Ji, Kashif Iqbal Sahibzada, Mengxue. The precise composition and structure of an ACP dictate its specific function and efficacy. For instance, some ACPs are designed to be cationic, enabling them to interact with and disrupt the membranes of cancer cells. Others are engineered to target specific cellular processes or signaling pathways crucial for tumor growth.
The research into ACPs encompasses a broad spectrum, from identifying novel peptide sequences with potent anticancer effects to understanding their detailed mechanisms of action. Databases like CancerPPD-2.A Novel Anticancer Peptide Derived from Bryopsis ...0 are being developed to curate information on anticancer proteins and peptides, including their sequences, lengths, experimental techniques used, and structures作者：R Ghavimi·2025·被引用次数：7—The peptides at a concentration of 0.05 μMsignificantly inhibit prostate cancer cellsand can prevent cancer cells from migrating in vitro(46). H-10 is a .... This growing body of knowledge is crucial for accelerating the discovery and development of new peptide-based cancer therapies.
Anticancer peptides employ diverse strategies to combat cancer. Many ACPs function by directly inducing cell death (apoptosis) in cancer cells, often by targeting their cell membranesReview Current research status of anti-cancer peptides. Their ability to selectively kill cancer cells while sparing healthy ones is a key advantageAnticancer peptides (ACPs)have exhibited tremendous potential in tumor treatment. However, low peptide delivery efficiency limits some ACPs' clinical .... Some ACPs can also interfere with tumor cell migration, a critical step in metastasis, thereby preventing the spread of cancer throughout the body作者：N Ghadiri·2024·被引用次数：48—Anticancer peptidescan be generated by rice and soy protein hydrolysis, specifically through the process of alcalase digestion of rice bran ....
Furthermore, ACPs are being investigated for their immunomodulatory propertiesReview Current research status of anti-cancer peptides. They can stimulate the immune system to recognize and attack cancer cells more effectively. This dual action, combining direct cytotoxic effects with immune system activation, makes ACPs particularly appealing as therapeutic agents作者：W Chiangjong·2020·被引用次数：403—A novel therapeutic strategy against cancer cells is the use ofanticancer peptides(ACPs). The physicochemical properties, amino acid composition and the .... The development of acid-activated ACPs, for example, aims to create more selective and efficient antitumor agents that respond to the acidic microenvironment often found in tumors.
The therapeutic potential of ACPs extends to various cancer types作者：A Geng·2025·被引用次数：17—Anti-cancer peptides (ACPs) area series of short peptides composed of 10-60 amino acidsthat can inhibit tumor cell proliferation or migration, .... Research has shown promising cytotoxic effects against lung cancer cells, prostate cancer cells, and even specific types of solid tumors.Anticancer peptides as novel immunomodulatory ... The development of peptide-based anticancer therapeutics includes hormone analogs like octreotide and leuprolide, which are already in clinical use, demonstrating the established role of peptides in cancer treatment.
Anticancer peptides offer several distinct advantages compared to conventional chemotherapy drugsAnticancer peptide: Physicochemical property, functional .... One of the most significant is their potential for reduced toxicity. Chemotherapy often causes severe side effects due to its broad impact on rapidly dividing cells, both cancerous and healthy. ACPs, with their targeted mechanisms, can potentially minimize damage to healthy tissues, leading to a better quality of life for patients.作者：M Xie·2020·被引用次数：288—Anti-cancer peptides (ACPs) area series of short peptides composed of 10–60 amino acidsthat can inhibit tumour cell proliferation or migration.
Another key advantage is their ability to overcome treatment resistance. Cancer cells can develop resistance to various drugs over time, rendering treatments ineffective. ACPs, with their novel mechanisms of action, may be able to bypass these resistance pathwaysBioactive peptides: an alternative therapeutic approach for .... Additionally, their small size allows for better penetration into tumor tissues, including reaching intracellular targets, which is a crucial requirement for developing effective anticancer agents.
The biocompatibility of peptides is also a notable benefitArtificial intelligence‐driven anticancer peptide discovery. Being naturally occurring molecules or derived from biological sources, they are generally well-tolerated by the body. This inherent biocompatibility, coupled with efficient therapeutic efficacy, makes ACPs a compelling alternative or complementary approach to existing cancer treatments.
Despite their immense promise, the development and clinical application of anticancer peptides face several challenges. One major hurdle is achieving efficient delivery of the peptides to the tumor site. Low peptide delivery efficiency can limit the effectiveness of some ACPs. Strategies to improve delivery include developing hybrid peptides, utilizing nanoparticle-based delivery systems, and designing peptides that are more stable in the bloodstream.
Another area of ongoing research is the discovery of novel ACPs. Artificial intelligence and computational biology are playing an increasingly important role in accelerating this process, enabling researchers to predict and design new peptides with enhanced anticancer activity. The exploration of peptides derived from diverse natural sources, such as insects and marine organisms, also holds significant potential for uncovering new therapeutic agents.
The field is also advancing through the creation of comprehensive databases and prediction models, such as CancerPPD-2.0 and ACP-CLB作者：SMP Vadevoo·2023·被引用次数：183—In the current market,peptide-based anticancer therapeuticsinclude hormone analogs such as octreotide, leuprolide, and goserelin.. These resources facilitate the systematic study and development of ACPs, paving the way for more effective and targeted cancer therapies in the future. As research continues, anticancer peptides are poised to become an integral part of the future of cancer treatment, offering new hope for patients worldwideAnti-cancer peptides: classification, mechanism of action ....
Join the newsletter to receive news, updates, new products and freebies in your inbox.